of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma mode
Metastatic disease after successful treatment of the primary tumor continues to be a therapeutic cha...
Contains fulltext : 83264.pdf (publisher's version ) (Open Access)Radboud Universi...
Contains fulltext : 59041.pdf (publisher's version ) (Open Access)INTRODUCTION: Wi...
Immune cells within the tumor can act either to promote growth or rejection of tumor cells. The aim ...
The tumor microenvironment can act so as to stimulate or reject tumor cells. Among the determining f...
Contains fulltext : 50329.pdf (publisher's version ) (Closed access)Because tumor ...
CD8-positive cells might play a crucial role in the therapeutic response to radiation, which has how...
of antigen specific recognition and cell mediated cytotoxicity by a modified lysispot assay in a rat...
Abstract ABSTRACT: BACKGROUND: Repeated administration of antibody-based therapies such as radioimmu...
Contains fulltext : 81772.pdf (publisher's version ) (Closed access)BACKGROUND: Ra...
Because tumor targeting with radiolabeled monoclonal anti-bodies is more efficient in small lesions,...
Contains fulltext : 95886.pdf (publisher's version ) (Closed access)BACKGROUND: Ra...
Contains fulltext : 47689.pdf (publisher's version ) (Closed access)BACKGROUND: De...
Item does not contain fulltextThe prospects for using pretargeted immuno-SPECT to monitor the respon...
Tumour immunity is a balance between immune mediators that promote tumor progression versus medi...
Metastatic disease after successful treatment of the primary tumor continues to be a therapeutic cha...
Contains fulltext : 83264.pdf (publisher's version ) (Open Access)Radboud Universi...
Contains fulltext : 59041.pdf (publisher's version ) (Open Access)INTRODUCTION: Wi...
Immune cells within the tumor can act either to promote growth or rejection of tumor cells. The aim ...
The tumor microenvironment can act so as to stimulate or reject tumor cells. Among the determining f...
Contains fulltext : 50329.pdf (publisher's version ) (Closed access)Because tumor ...
CD8-positive cells might play a crucial role in the therapeutic response to radiation, which has how...
of antigen specific recognition and cell mediated cytotoxicity by a modified lysispot assay in a rat...
Abstract ABSTRACT: BACKGROUND: Repeated administration of antibody-based therapies such as radioimmu...
Contains fulltext : 81772.pdf (publisher's version ) (Closed access)BACKGROUND: Ra...
Because tumor targeting with radiolabeled monoclonal anti-bodies is more efficient in small lesions,...
Contains fulltext : 95886.pdf (publisher's version ) (Closed access)BACKGROUND: Ra...
Contains fulltext : 47689.pdf (publisher's version ) (Closed access)BACKGROUND: De...
Item does not contain fulltextThe prospects for using pretargeted immuno-SPECT to monitor the respon...
Tumour immunity is a balance between immune mediators that promote tumor progression versus medi...
Metastatic disease after successful treatment of the primary tumor continues to be a therapeutic cha...
Contains fulltext : 83264.pdf (publisher's version ) (Open Access)Radboud Universi...
Contains fulltext : 59041.pdf (publisher's version ) (Open Access)INTRODUCTION: Wi...